Health / Medical Topics

    Histone Methyl Transferase EZH2 Inhibitor E7438

    An orally available, small molecule selective and S-adenosyl methionine (SAM) competitive inhibitor of histone methyl transferase EZH2, with potential antineoplastic activity. Upon oral administration, E7438 selectively inhibits the activity of both wild-type and mutated forms of EZH2. Inhibition of EZH2 specifically prevents the methylation of histone H3 lysine 27 (H3K27). This decrease in histone methylation alters gene expression patterns associated with cancer pathways and results in decreased tumor cell proliferation in EZH2 mutated cancer cells. EZH2, which belongs to the class of histone methyltransferases (HMTs), is overexpressed or mutated in a variety of cancer cells and plays a key role in tumor cell proliferation. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Histone H4I protein (103 aa, ~11 kDa) is encoded by the human HIST1H4I gene. This protein plays a role in nucleating the…
    Histone H4 is a core subunit of the eukaryotic nucleosome complex. Histones are basic nuclear proteins responsible for the nucleosome structure of…
    Histone H3.3 (136 aa, ~15 kDa) is encoded by the human H3F3A gene. This protein plays a role in chromosomal structure. …
    Histone H3.1 (136 aa, ~15 kDa) is encoded by the human HIST1H3B gene. This protein plays a role in the formation of…
    A post-translationally modified form of histone H3 where the lysine residue at position 4 is trimethylated. This modification may be a marker…
    The lysine residue found at amino acid position 9 in the histone H3 protein. Methylation of this residue may be a marker…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact